Opinion

Video

Reducing Risk of Thrombosis in Patients With PV

Key opinion leaders discuss their treatment targets for low- and high-risk patients with polycythemia vera.

Related Videos
Dr Kishtagari on Pelabresib Plus Ruxolitinib in JAK Inhibitor–Naive Myelofibrosis
2 expert is featured in this series.
2 expert is featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
Al Malki
3 experts are featured in this series.